NECTAR Trademark

Trademark Overview


On Wednesday, September 28, 2022, a trademark application was filed for NECTAR with the United States Patent and Trademark Office. The USPTO has given the NECTAR trademark a serial number of 97611354. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, January 22, 2025. This trademark is owned by Nectar Life Sciences Inc.. The NECTAR trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Telemedicine services and telemedicine treatment services for treatment of conditions caused by atopy, namely, for determining a treatment plan with prescription allergy medication in a formulation customized according to results of a patient's allergy test; Telemedicine services and telemedicine treatment services for treatment of conditions caused by atopy, namely, for determining a treatment plan with prescription allergy medication in a formulation customized according to results of a patient administered allergy test; Telemedicine services and telemedicine treatment services for treatment of conditions caused by atopy, namely, for determining a treatment plan with prescription allergy medication in a formulation customized according to results of a patient's at home allergy test; Telemedicine services and telemedicine treatment services for treatment of conditions caused by atopy, namely, for determining a treatment plan with prescription allergy medication in a formulation custom...

General Information


Serial Number97611354
Word MarkNECTAR
Filing DateWednesday, September 28, 2022
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, January 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the word "Nectar" and a design based on a circle above ellipses of varying sizes.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesTelemedicine services and telemedicine treatment services for treatment of conditions caused by atopy, namely, for determining a treatment plan with prescription allergy medication in a formulation customized according to results of a patient's allergy test; Telemedicine services and telemedicine treatment services for treatment of conditions caused by atopy, namely, for determining a treatment plan with prescription allergy medication in a formulation customized according to results of a patient administered allergy test; Telemedicine services and telemedicine treatment services for treatment of conditions caused by atopy, namely, for determining a treatment plan with prescription allergy medication in a formulation customized according to results of a patient's at home allergy test; Telemedicine services and telemedicine treatment services for treatment of conditions caused by atopy, namely, for determining a treatment plan with prescription allergy medication in a formulation customized according to results of a patient's direct-to-consumer allergy test; Telemedicine services and telemedicine treatment services for treatment of conditions caused by atopy, namely, information regarding a treatment plan with customized pharmaceutical preparations for developing tolerance to allergens

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, October 16, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNectar Life Sciences Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10033

Trademark Events


Event DateEvent Description
Saturday, October 1, 2022NEW APPLICATION ENTERED
Sunday, October 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 18, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, July 12, 2023ASSIGNED TO EXAMINER
Thursday, July 13, 2023NON-FINAL ACTION WRITTEN
Thursday, July 13, 2023NON-FINAL ACTION E-MAILED
Thursday, July 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 12, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, October 12, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, January 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 13, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 31, 2024FINAL REFUSAL WRITTEN
Wednesday, January 31, 2024FINAL REFUSAL E-MAILED
Wednesday, January 31, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, April 29, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, April 29, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, July 18, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, July 18, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, July 23, 2024LETTER OF SUSPENSION E-MAILED
Tuesday, July 23, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, July 23, 2024SUSPENSION LETTER WRITTEN
Friday, January 3, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, January 22, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 22, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 22, 2025ASSIGNED TO LIE